Back to search

Netherlands· NL-2ecea58157aa

Duloxetine Amarox 60 mg, harde maagsapresistente capsules

A duloxetine product containing duloxetinehydrochloride, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC N06AX21

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDuloxetine Amarox 60 mg, harde maagsa…ATCN06AX21REGISTER NO.NL-2ecea58157aaPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Duloxetine is registered in 16 of 19 countries.

Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Duloxetine · ATC N06AX21

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of duloxetine costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Duloxetine · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.57
  • IT Italy$0.67
  • US United States$0.28 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DULOXETINEHYDROCHLORIDE
Manufacturer
Amarox Pharma B.V.
Country
Netherlands (NL)
ATC code
N06AX21
ATC class
Duloxetine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    122274

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

501 interactions on record for duloxetine.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Duloxetine · interactions on record

501 records

  • 33 severe
  • 247 moderate
  • 23 minor
  • 130 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

68 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Duloxetine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All duloxetine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dulasolan, Duloxetin +pharma
  • Belgium · Duloxetin Ab, Duloxétine Ab
  • Bulgaria · Dulasolan, Duxet
  • Cyprus · Dulox, Duloxetine Accord
  • Czechia · Dolyxan, Dulasolan
  • Germany · Dulasolan, Duloxalta
  • Denmark · Aritavi, Duciltia
  • Estonia · Dulsevia, Onelar
  • Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
  • Finland · Duloxetin Stada, Duloxetine Accord
  • France · Duloxetine Accord, Duloxetine Almus
  • United Kingdom (Northern Ireland) · Depalta, Duciltia
  • Greece · Duciltia, Duloxetine Liconsa
  • Croatia · Dolyxan, Duloksetin Pliva
  • Hungary · Duciltia, Dulodet
  • Ireland · Duloxetine Accord, Duloxetine Clonmel
  • Iceland · Aritavi, Cymbalta
  • Italy · Alikres, Dulex
  • Liechtenstein · Cymbalta, Duloxetine Lilly
  • Lithuania · Dulsevia
  • Luxembourg · Duloxetin Ab, Duloxetine Liconsa
  • Latvia · Dulsevia
  • Malta · Onelar
  • Norway · Cymbalta, Duloxetin Krka
  • Poland · Aurodulox, Depratal
  • Portugal · Duloxetina Alter, Duloxetina Amperlem
  • Romania · Dozzex, Duloxetină Dr. Reddy's
  • Sweden · Aritavi, Dulmis
  • Slovenia · Duloksetin Sandoz, Dulsevia
  • Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e574598f-d768-46eb-890d-3be9e25c3ecc
GET /v1/drugs/e574598f-d768-46eb-890d-3be9e25c3ecc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122274_smpc.pdf",
  "strength": null,
  "atc_label": "Duloxetine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122274",
  "excipients": [
    "AMMONIA (E 527)",
    "CARBOXYMETHYLETHYLCELLULOSE",
    "CROSPOVIDON (E 1202)",
    "GELATINE (E 441)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN (E 132)",
    "KALIUMHYDROXIDE (E 525)",
    "MACROGOL 400",
    "MAÏSZETMEEL",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 30 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SACCHAROSE",
    "SCHELLAK (E 904)",
    "SUIKERZETMEELBOLLETJES",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT"
  ],
  "substances": [
    "DULOXETINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122274.pdf",
  "authorised_at": "2018/02/20",
  "procedure_number": "NL/H/4619/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122274",
  "additional_monitoring": "N"
}

See everything about duloxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.